MedTrace Logo

Population Pharmacokinetics of Propafenone and Propranolol in Children Patients

NCT05463614 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-07-19

No results posted yet for this study

Summary

The use of propafenone and propranolol in children during clinical treatment was depending mostly on experience. Besides, there was no recommended dose for children in drug instruction. Therefore, the investigators' aim is to study the pharmacokinetics and pharmacodynamics in children.

Conditions

Interventions

DRUG

Propafenone and Propranolol

Propafenone Hydrochloride Tablets, 100-200mg, 1 or 2 times per day; Propranolol Hydrochloride Sustained-Release Capsules, 40mg, 1 times per day

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2022-08-01
Completion
2025-12-01
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05463614 on ClinicalTrials.gov